Hiremath S - Search Results

1

Review - current opinion in cardiology hypertension in chronic kidney disease.

Alqudsi M, Hiremath S, Velez JCQ. Alqudsi M, et al. Among authors: hiremath s. Curr Opin Cardiol. 2020 Jul;35(4):360-367. doi: 10.1097/HCO.0000000000000758. Curr Opin Cardiol. 2020. PMID: 32487944

2

Spironolactone for difficult to control hypertension in chronic kidney disease: an analysis of safety and efficacy.

Heshka J, Ruzicka M, Hiremath S, McCormick BB. Heshka J, et al. Among authors: hiremath s. J Am Soc Hypertens. 2010 Nov-Dec;4(6):295-301. doi: 10.1016/j.jash.2010.09.006. J Am Soc Hypertens. 2010. PMID: 21130976

3

Accuracy of cystatin C-based estimates of glomerular filtration rate in kidney transplant recipients: a systematic review.

Harman G, Akbari A, Hiremath S, White CA, Ramsay T, Kokolo MB, Craig J, Knoll GA. Harman G, et al. Among authors: hiremath s. Nephrol Dial Transplant. 2013 Mar;28(3):741-57. doi: 10.1093/ndt/gfs498. Epub 2012 Dec 28. Nephrol Dial Transplant. 2013. PMID: 23275574 Review.

4

Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis.

Bose B, Badve SV, Hiremath SS, Boudville N, Brown FG, Cass A, de Zoysa JR, Fassett RG, Faull R, Harris DC, Hawley CM, Kanellis J, Palmer SC, Perkovic V, Pascoe EM, Rangan GK, Walker RJ, Walters G, Johnson DW. Bose B, et al. Among authors: hiremath ss. Nephrol Dial Transplant. 2014 Feb;29(2):406-13. doi: 10.1093/ndt/gft378. Epub 2013 Sep 15. Nephrol Dial Transplant. 2014. PMID: 24042021 Review.

5

Catheter-based renal sympathetic denervation: limitations to and gaps in the evidence.

Hiremath S, Froeschl M, Ruzicka M. Hiremath S, et al. Curr Opin Cardiol. 2014 Jul;29(4):336-43. doi: 10.1097/HCO.0000000000000076. Curr Opin Cardiol. 2014. PMID: 24859619 Review.

6

The association of urinary sodium excretion and the need for renal replacement therapy in advanced chronic kidney disease: a cohort study.

Mazarova A, Molnar AO, Akbari A, Sood MM, Hiremath S, Burns KD, Ramsay TO, Mallick R, Knoll GA, Ruzicka M. Mazarova A, et al. Among authors: hiremath s. BMC Nephrol. 2016 Sep 5;17(1):123. doi: 10.1186/s12882-016-0338-z. BMC Nephrol. 2016. PMID: 27596141 Free PMC article.

7

Intensive blood pressure lowering in chronic kidney disease: the time has come.

Ruzicka M, Hiremath S. Ruzicka M, et al. Among authors: hiremath s. Curr Opin Nephrol Hypertens. 2017 May;26(3):197-204. doi: 10.1097/MNH.0000000000000316. Curr Opin Nephrol Hypertens. 2017. PMID: 28198732 Review.

8

Precision Medicine for Hypertension Management in Chronic Kidney Disease: Relevance of SPRINT for Therapeutic Targets in Nondiabetic Renal Disease.

Ruzicka M, Burns KD, Hiremath S. Ruzicka M, et al. Among authors: hiremath s. Can J Cardiol. 2017 May;33(5):611-618. doi: 10.1016/j.cjca.2017.01.007. Epub 2017 Jan 20. Can J Cardiol. 2017. PMID: 28365055 Review.

9

Longitudinal Blood Pressure in Late-Stage Chronic Kidney Disease and the Risk of End-Stage Kidney Disease or Mortality (Best Blood Pressure in Chronic Kidney Disease Study).

Sood MM, Akbari A, Manuel DG, Ruzicka M, Hiremath S, Zimmerman D, McCormick B, Taljaard M. Sood MM, et al. Among authors: hiremath s. Hypertension. 2017 Dec;70(6):1210-1218. doi: 10.1161/HYPERTENSIONAHA.117.09855. Epub 2017 Oct 23. Hypertension. 2017. PMID: 29061722

10

The case for cautious consumption: NSAIDs in chronic kidney disease.

Sriperumbuduri S, Hiremath S. Sriperumbuduri S, et al. Among authors: hiremath s. Curr Opin Nephrol Hypertens. 2019 Mar;28(2):163-170. doi: 10.1097/MNH.0000000000000473. Curr Opin Nephrol Hypertens. 2019. PMID: 30531470 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

493 results

Search Page